专利检索 ap:("Oryzon Genomics, S.A.") AND inv:"Nuria Valls Vidal" 第 1 页

1.

发明申请
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 有权
标题翻译：（HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS

公开(公告)号：US20150025054A1

公开(公告)日：2015-01-22

申请号：US14352711

申请日：2012-10-22

申请人： ORYZON GENOMICS, S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estirate Martínez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Lar

IPC分类号： C07D451/04 , C07D405/12 , C07D309/04 , C07D223/12 , C07D205/04 , C07D221/20 , C07D215/42 , C07D401/12 , C07D211/58 , C07D207/14

CPC分类号： C07D211/58 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D215/42 , C07D221/20 , C07D223/12 , C07D309/04 , C07D309/14 , C07D335/02 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D451/04

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

摘要翻译： 本发明涉及（异）芳基环丙胺化合物，特别包括本文所述和定义的式I化合物及其在治疗中的用途，包括例如治疗或预防癌症，神经疾病或病症，或病毒感染。

2.

发明申请
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 审中-公开

公开(公告)号：US20180354902A1

公开(公告)日：2018-12-13

申请号：US15911535

申请日：2018-03-05

申请人： Oryzon Genomics, S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： C07D211/58 , C07D335/02 , C07D309/04 , C07D211/56 , C07D211/26 , C07D209/96 , C07D207/14 , C07D207/09 , C07D205/04 , C07D451/04 , C07D417/12 , C07D405/12 , C07D401/12 , C07D401/04 , C07D223/12 , C07D221/20 , C07D215/42 , C07D309/14

CPC分类号： C07D211/58 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D215/42 , C07D221/20 , C07D223/12 , C07D309/04 , C07D309/14 , C07D335/02 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D451/04

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

3.

发明授权
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors 有权

公开(公告)号：US09670136B2

公开(公告)日：2017-06-06

申请号：US15254020

申请日：2016-09-01

申请人： Oryzon Genomics S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Àngeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： A61K31/135 , C07C211/36 , C07D213/74 , C07C271/24 , C07C275/26 , C07D231/12 , C07D207/14 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D213/30 , C07D213/38 , C07D307/52 , C07C311/08 , C07C311/21 , C07C211/37 , C07C215/46 , C07C217/54 , C07C209/28 , C07C211/38 , C07C269/00 , C07C273/18 , C07C211/40 , C07C213/00 , C07C215/64 , C07C217/74 , C07C273/00 , C07D213/57 , C07D213/73 , C07D231/56 , C07D333/20

CPC分类号： C07C211/36 , C07B2200/07 , C07C209/28 , C07C211/37 , C07C211/38 , C07C211/40 , C07C213/00 , C07C215/46 , C07C215/64 , C07C217/54 , C07C217/74 , C07C269/00 , C07C271/24 , C07C273/00 , C07C273/18 , C07C275/26 , C07C311/08 , C07C311/21 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/14 , C07D213/30 , C07D213/38 , C07D213/57 , C07D213/73 , C07D213/74 , C07D231/12 , C07D231/56 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D307/52 , C07D333/20

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

4.

发明申请
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 审中-公开

公开(公告)号：US20180079709A1

公开(公告)日：2018-03-22

申请号：US15497556

申请日：2017-04-26

申请人： Oryzon Genomics S.A.

发明人： Alberto ORTEGA MUÑOZ , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Àngeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： C07C211/36 , C07D333/20 , C07C273/00 , C07D213/57 , C07D213/73 , C07D231/56 , C07C213/00 , C07C215/64 , C07C217/74 , C07C211/40 , C07C217/54 , C07C215/46 , C07C311/21 , C07C311/08 , C07C273/18 , C07C209/28 , C07C211/38 , C07C269/00 , C07D213/74 , C07D307/52 , C07D213/38 , C07D213/30 , C07D295/26 , C07D295/135 , C07D295/096 , C07D277/28 , C07D207/14 , C07D231/12 , C07C275/26 , C07C271/24

CPC分类号： C07C211/36 , C07B2200/07 , C07C209/28 , C07C211/37 , C07C211/38 , C07C211/40 , C07C213/00 , C07C215/46 , C07C215/64 , C07C217/54 , C07C217/74 , C07C269/00 , C07C271/24 , C07C273/00 , C07C273/18 , C07C275/26 , C07C311/08 , C07C311/21 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/14 , C07D213/30 , C07D213/38 , C07D213/57 , C07D213/73 , C07D213/74 , C07D231/12 , C07D231/56 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D307/52 , C07D333/20

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

5.

发明授权
Cyclopropylamine derivatives useful as LSD1 inhibitors 有权

公开(公告)号：US09676701B2

公开(公告)日：2017-06-13

申请号：US14640395

申请日：2015-03-06

申请人： Oryzon Genomics, S.A.

发明人： Matthew Colin Thor Fyfe , Alberto Ortega Muñoz , Julio Castro-Palomino Laria , Marc Martinell Pedemonte , Maria de los Angeles Estiarte-Martinez , Nuria Valls Vidal

IPC分类号： C07C211/40 , C07C215/64 , C07C217/64 , C07C217/74 , C07C255/53 , C07C255/54 , C07C311/08 , C07C311/09 , C07C311/21 , C07D213/38 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/57 , C07D239/26 , C07D277/28 , C07D333/20 , C07D401/04 , C07D405/04 , C07D409/04 , C07C255/59 , C07D213/64 , C07D401/10 , C07D405/10 , C07D409/10

CPC分类号： C07C211/40 , C07B2200/07 , C07C215/64 , C07C217/74 , C07C255/53 , C07C255/54 , C07C255/59 , C07C311/08 , C07C311/09 , C07C311/21 , C07C2601/02 , C07D213/38 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/57 , C07D213/64 , C07D239/26 , C07D277/28 , C07D333/20 , C07D401/04 , C07D401/10 , C07D405/04 , C07D405/10 , C07D409/04 , C07D409/10

摘要： The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I), and their use in therapy, including e.g. in the treatment or prevention of cancer, a neurological disease or condition, or viral infection.

6.

发明申请
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 有权
标题翻译：（HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS

公开(公告)号：US20140256729A1

公开(公告)日：2014-09-11

申请号：US14352719

申请日：2012-10-22

申请人： ORYZON GENOMICS, S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Ángeles Estiarte Martínez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： C07C211/36 , C07C209/28 , C07D295/135 , C07D213/38 , C07C275/26 , C07D207/14 , C07C271/24 , C07C273/18 , C07C211/38 , C07C269/00 , C07D277/28

CPC分类号： C07C211/36 , C07B2200/07 , C07C209/28 , C07C211/37 , C07C211/38 , C07C211/40 , C07C213/00 , C07C215/46 , C07C215/64 , C07C217/54 , C07C217/74 , C07C269/00 , C07C271/24 , C07C273/00 , C07C273/18 , C07C275/26 , C07C311/08 , C07C311/21 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/14 , C07D213/30 , C07D213/38 , C07D213/57 , C07D213/73 , C07D213/74 , C07D231/12 , C07D231/56 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D307/52 , C07D333/20

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and theft use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

摘要翻译： 本发明涉及（异）芳基环丙胺化合物，特别包括本文所述和定义的式（I）化合物和治疗中的盗窃用途，包括例如治疗或预防癌症，神经疾病或病症，或病毒感染。

7.

发明授权
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors 有权

公开(公告)号：US09944601B2

公开(公告)日：2018-04-17

申请号：US15271772

申请日：2016-09-21

申请人： Oryzon Genomics, S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Àngeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： C07D211/58 , C07D309/04 , C07D309/14 , C07D215/42 , C07D221/20 , C07D223/12 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D451/04 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D335/02

CPC分类号： C07D211/58 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D215/42 , C07D221/20 , C07D223/12 , C07D309/04 , C07D309/14 , C07D335/02 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D451/04

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

8.

发明授权
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors 有权
标题翻译：（杂芳基）芳基环丙胺化合物作为LSD1抑制剂

公开(公告)号：US09487512B2

公开(公告)日：2016-11-08

申请号：US14352711

申请日：2012-10-22

申请人： ORYZON GENOMICS, S.A.

发明人： Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria

IPC分类号： C07D451/04 , C07D309/04 , C07D309/14 , C07D215/42 , C07D221/20 , C07D223/12 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D211/58

CPC分类号： C07D211/58 , C07D205/04 , C07D207/09 , C07D207/14 , C07D209/96 , C07D211/26 , C07D211/56 , C07D215/42 , C07D221/20 , C07D223/12 , C07D309/04 , C07D309/14 , C07D335/02 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D451/04

摘要： The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

摘要翻译： 本发明涉及（异）芳基环丙胺化合物，特别包括本文所述和定义的式I化合物及其在治疗中的用途，包括例如治疗或预防癌症，神经疾病或病症，或病毒感染。